Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment
This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…
Certara2026年6月2日
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators
Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…
Certara2026年5月26日
Advancing In Vivo CAR-T with QSP
Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…
Certara2026年5月12日
Certara IQ™ Demo
Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…
Certara2026年5月12日
Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome
QSP modeling reveals how anti-amyloid therapies impact tau biomarkers and cognitive outcomes in Alzheimer’s disease.
Certara2026年5月4日
Modeling CAR-T Outcomes in Multiple Myeloma
Learn how QSP modeling predicts CAR-T therapy outcomes, identifies patient-specific response drivers, and supports multi-antigen…
Certara2026年5月4日
Modeling T-cell Exhaustion in Immunotherapy
Discover how QSP modeling predicts T-cell exhaustion, relapse risk, and optimal dosing strategies for T-cell…
Certara2026年5月4日
Modeling Hematopoiesis in MDS and AML with QSP
Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…
Certara2026年5月1日
IO Simulator: A QSP Platform for Immuno-Oncology
This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…
Certara2026年4月30日
